| 2001 |
GCP60 (ACBD3) was identified as a peripheral Golgi membrane protein that interacts with the C-terminal cytoplasmic domain of the integral membrane protein giantin; overexpression of the GCP60 C-terminal domain caused Golgi disassembly and blocked ER-to-Golgi protein transport. |
Yeast two-hybrid screening, immunofluorescence, immunoelectron microscopy, overexpression assay |
The Journal of biological chemistry |
Medium |
11590181
|
| 2001 |
PAP7 (ACBD3) interacts with both the mitochondrial peripheral-type benzodiazepine receptor (PBR) and the cytosolic PKA regulatory subunit RIα; overexpression of full-length PAP7 increased hCG-induced steroid production, while a dominant-negative partial PAP7 and antisense oligonucleotides inhibited hormone-stimulated cholesterol transport and steroidogenesis in MA-10 Leydig cells. |
Yeast two-hybrid, GST pulldown, antisense oligonucleotide knockdown, steroid production assay |
Molecular endocrinology (Baltimore, Md.) |
Medium |
11731621
|
| 2003 |
PAP7 (ACBD3) functions as an A-kinase anchoring protein (AKAP) that localizes to the trans-Golgi apparatus and mitochondria in Leydig cells; inhibition of PAP7 expression reduced hormone-induced cholesterol transport into mitochondria and decreased steroid formation, suggesting it targets PKA to PBR-rich organelles. |
Immunofluorescence confocal microscopy, antisense inhibition, steroid formation assay |
The Journal of steroid biochemistry and molecular biology |
Medium |
12943713
|
| 2006 |
GCP60 (ACBD3) preferentially interacts with a caspase-generated golgin-160 fragment (residues 140–311) and prevents its nuclear translocation; cells overexpressing GCP60 showed increased sensitivity to staurosporine-induced apoptosis. |
Yeast two-hybrid, co-immunoprecipitation, overexpression/localization assay, apoptosis assay |
The Journal of biological chemistry |
Medium |
16870622
|
| 2007 |
A single redox-sensitive cysteine (Cys-463) in GCP60 (ACBD3) is critical for its interaction with the golgin-160 caspase fragment (residues 140–311); mutation of Cys-463 abolished interaction in vitro and disrupted Golgi retention of the fragment; oxidation by H2O2 or a nitric oxide donor restored the interaction. |
Site-directed mutagenesis, in vitro binding assay, cellular localization assay, oxidation experiments |
The Journal of biological chemistry |
High |
17711851
|
| 2007 |
ACBD3 associates with the Golgi in neurons and interphase progenitor cells but becomes cytosolic upon Golgi fragmentation during mitosis; ACBD3 interacts with Numb through an essential Numb domain, and cytosolic ACBD3 acts synergistically with Numb to specify neural cell fates; loss- and gain-of-function mouse mutants share phenotypic similarities linking ACBD3 to asymmetric cell division. |
Co-immunoprecipitation, live/fixed-cell imaging, loss-of-function/gain-of-function mouse models |
Cell |
High |
17418793
|
| 2011 |
ACBD3 interacts with multiple Aichi virus non-structural proteins (2B, 2BC, 2C, 3A, 3AB) and directly with PI4KB; this ACBD3–PI4KB interaction recruits PI4KB to viral RNA replication sites, enabling PI4P synthesis essential for Aichi virus RNA replication; knockdown of ACBD3 or PI4KB suppressed replication. |
Co-immunoprecipitation, siRNA knockdown, immunofluorescence microscopy, viral replication assay |
The EMBO journal |
High |
22124328
|
| 2012 |
Multiple picornavirus 3A proteins (Aichi virus, bovine kobuvirus, poliovirus, coxsackievirus B2/B3/B5, HRV14) co-purify with ACBD3; ACBD3 itself binds PI4KIIIβ in the absence of 3A; alanine-scanning mutagenesis of Aichi virus 3A identified residues that selectively abolish PI4KIIIβ co-purification without affecting ACBD3 binding; N-terminal glycines of some 3A proteins are myristoylated. |
Affinity purification with Strep-tag, mass spectrometry, Western blotting, alanine-scanning mutagenesis, siRNA knockdown, viral replication assay |
Journal of virology |
High |
22258260
|
| 2012 |
ACBD3 recruits the protein phosphatase PPM1L to ER–Golgi membrane contact sites via its GOLD domain, implicating ACBD3 in ceramide trafficking regulation at the ER–Golgi interface. |
Co-immunoprecipitation, domain mapping, subcellular fractionation/localization |
FEBS letters |
Medium |
22796112
|
| 2013 |
ACBD3 interacts with TBC1D22A and TBC1D22B (putative Rab33 GAPs) via the same binding site on ACBD3 used by PI4KB; TBC1D22A/B and PI4KB interactions with ACBD3 are mutually exclusive, suggesting a competitive regulatory mechanism for PI4KB recruitment. |
Affinity purification–mass spectrometry, mammalian two-hybrid, co-immunoprecipitation, domain mapping |
mBio |
Medium |
23572552
|
| 2013 |
ACBD3 forms a complex with Rhes and mutant huntingtin (mHtt) in the striatum; ACBD3 levels are elevated in HD striatum; ACBD3 deletion abolishes mHtt-mediated neurotoxicity, while overexpression increases it, placing ACBD3 downstream of Rhes/mHtt as a mediator of HD cytotoxicity. |
Co-immunoprecipitation, ACBD3 deletion/overexpression, cell viability assay, Western blot in HD mouse brain and patient tissue |
Cell reports |
Medium |
24012756
|
| 2013 |
ACBD3 interacts with poliovirus 3A proteins at viral RNA replication sites; siRNA-mediated downregulation of ACBD3 significantly increased poliovirus replication, indicating ACBD3 can negatively modulate enterovirus replication; the amino acid at position 12 of 3A influences sensitivity to this effect. |
Co-immunoprecipitation, siRNA knockdown, viral growth assay, replicon assay, immunofluorescence |
Journal of virology |
Medium |
23926333
|
| 2013 |
ACBD3 depletion did not affect PI4KIIIβ recruitment to coxsackievirus B3 (CVB3) replication organelles and did not impair CVB3 RNA replication, demonstrating that CVB3 recruits PI4KIIIβ by an ACBD3-independent mechanism (NEGATIVE finding for CVB3). |
siRNA knockdown, immunofluorescence, viral replication assay |
Journal of virology |
Medium |
24352456
|
| 2014 |
The viral protein/ACBD3/PI4KB complex stimulates PI4KB kinase activity in vitro; Aichi virus 3A and 3AB proteins stimulate PI4KB activity through forming a 3A(3AB)/ACBD3/PI4KB complex, enhancing PI4P synthesis at replication organelles and facilitating viral replication complex formation. |
In vitro kinase assay, siRNA knockdown, immunofluorescence, PI4P quantification |
Journal of virology |
High |
24672044
|
| 2016 |
NMR structure of the PI4KB–ACBD3 complex was determined; ACBD3 recruits PI4KB to membranes both in vitro and in vivo, and membrane recruitment of PI4KB by ACBD3 increases its enzymatic activity; ACBD3:PI4KB complex formation is essential for proper Golgi PI4P homeostasis. |
NMR structure determination, in vitro membrane recruitment assay, enzymatic activity assay, cellular localization experiments |
Scientific reports |
High |
27009356
|
| 2016 |
Salmonella effectors SseF and SseG interact directly with ACBD3; SseG binds ACBD3 alone, while SseF binding requires SseG; ACBD3 knockdown reduces Golgi association of Salmonella-containing vacuoles, and ACBD3-interaction-deficient SseF/SseG mutants display an intracellular replication defect. |
Yeast two-hybrid, co-immunoprecipitation, GST pulldown, siRNA knockdown, confocal microscopy, bacterial replication assay |
mBio |
High |
27406559
|
| 2016 |
Crystal structure of the ACBD3 GOLD domain revealed a unique N terminus that mediates interaction with Aichi virus 3A; hydrogen-deuterium exchange mass spectrometry mapped the PI4KIIIβ–ACBD3 and ACBD3–3A interfaces; 3A directly activates PI4KIIIβ and this is sensitized by ACBD3; rationally designed interface mutations abrogated kinase activation by ACBD3. |
Crystal structure determination, HDX-MS, in vitro kinase reconstitution, site-directed mutagenesis |
Structure (London, England : 1993) |
High |
27989622
|
| 2017 |
Crystal structures of Aichi virus and bovine kobuvirus 3A proteins in complex with the ACBD3 GOLD domain showed that viral 3A proteins act as molecular harnesses to stabilize ACBD3 at target membranes; molecular dynamics simulation revealed 3A-mediated ACBD3 stabilization at lipid bilayers. |
Crystal structure determination, molecular dynamics simulation |
Structure (London, England : 1993) |
High |
28065508
|
| 2017 |
ACBD3 interacts with EV71 3A protein; this interaction is required for EV71 RNA replication and plaque formation; EV71 3A redirects ACBD3 to viral replication sites; I44A or H54Y substitutions in 3A disrupt ACBD3 binding and impair replication. |
cDNA library screening, co-immunoprecipitation, ACBD3 CRISPR knockout/knockdown, immunofluorescence, viral replication assay, mutagenesis |
Scientific reports |
High |
28303920
|
| 2017 |
EV71 3A protein stimulates the ACBD3–PI4KB interaction; ACBD3 is required for PI4KB recruitment to EV71 RNA replication sites; EV71 infection induces PI4P production in an ACBD3- and PI4KB-dependent manner; I44A or H54Y in 3A abolish stimulation of ACBD3–PI4KB interaction. |
Co-immunoprecipitation, siRNA knockdown, immunofluorescence, PI4P quantification, mutagenesis |
Journal of virology |
High |
28701404
|
| 2017 |
ACBD3 interacts with Golgin45 via its GOLD domain; ACBD3 co-expression increases Golgin45 Golgi targeting; ACBD3 recruits TBC1D22 (a Rab33b GAP) to a multi-protein complex containing Golgin45 and GRASP55, suggesting a scaffolding role in organizing Golgi stacking proteins. |
Proteomics, co-immunoprecipitation, confocal microscopy, domain mapping |
FEBS letters |
Medium |
28777890
|
| 2018 |
AiV non-structural proteins (2B, 2BC, 2C, 3A, 3AB) interact with ACBD3, OSBP, VAP-A/B, and SAC1; ACBD3 mediates recruitment of OSBP-VAP cholesterol transport machinery to AiV replication organelles through protein–protein interactions; silencing OSBP, VAP-A/B, or SAC1 inhibited AiV replication; cholesterol accumulates at AiV replication organelles in an OSBP-dependent manner. |
Co-immunoprecipitation, siRNA knockdown, immunofluorescence, cholesterol staining, electron microscopy |
Journal of virology |
Medium |
29367253
|
| 2019 |
ACBD3 knockout impaired replication of representative viruses from four enterovirus and two rhinovirus species; PI4KB recruitment to replication organelles requires ACBD3; absence of ACBD3 causes 3A mis-localization to ER instead of Golgi; ACB and CAR domains of ACBD3 are dispensable, while other domains are required for 3A-mediated PI4KB recruitment. |
CRISPR knockout, rescue with ACBD3/PI4KB mutants, immunofluorescence, viral replication assay, domain deletion analysis |
mBio |
High |
30755512
|
| 2019 |
SAXS analysis showed that the ACBD3:PI4KB complex adopts highly flexible conformations (both compact and extended), while 14-3-3:PI4KB:Rab11 has 2:1:1 stoichiometry; membrane is required for formation of the ACBD3:PI4KB:Rab11 complex at physiological concentrations. |
Small-angle X-ray scattering (SAXS), in vitro reconstitution |
Scientific reports |
Medium |
30679637
|
| 2019 |
Crystal structures of ACBD3 GOLD domain complexed with 3A proteins from poliovirus, EV-A71, EV-D68, and rhinovirus B14 revealed convergent structural mechanisms for 3A–ACBD3 interaction; 3A–3A interactions drive assembly of ACBD3–3A heterotetramers; structure-guided mutations disrupting these interfaces impaired PI4KB recruitment and enterovirus replication. |
Crystal structure determination, molecular dynamics, co-immunoprecipitation, viral replication assay, mutagenesis |
PLoS pathogens |
High |
31381608
|
| 2019 |
ACBD3 is required for FAPP2-mediated glucosylceramide transport; ACBD3 knockdown causes Golgi fragmentation, FAPP2 dispersal from trans-Golgi network, and abnormal sphingolipid metabolism; re-expression of full-length ACBD3 rescues these defects. |
Co-immunoprecipitation, siRNA knockdown, quantitative lipidomics, confocal microscopy, rescue experiment |
Journal of molecular cell biology |
Medium |
29750412
|
| 2021 |
ACBD3 knockout cells exhibit enlarged Golgi with absence of stacks and ribbon-like formation, confirming ACBD3 role in Golgi stacking; cholesterol levels and mitochondrial structure/function are not altered in ACBD3-KO HEK293 and HeLa cells; decreased sphingomyelins with normal ceramide and sphingomyelin synthase activity reveal ACBD3 role in ceramide transport from ER to Golgi. |
CRISPR knockout, electron microscopy, Golgi morphology analysis, lipidomics, mitochondrial function assays |
International journal of molecular sciences |
Medium |
34298889
|
| 2021 |
ACBD3 directly interacts with KDEL receptor and recruits PKA to the Golgi; ACBD3 depletion causes accelerated retrograde trafficking of KDEL receptor by altering its interaction with PKA and Arf1/ArfGAP1, leading to increased Arf1-GTP-dependent tubular carrier formation; ACBD3 functions as a negative regulator of PKA activity on KDEL receptor. |
Proximity-based in vivo tagging, co-immunoprecipitation, siRNA knockdown, live-cell imaging, trafficking assay |
BMC biology |
Medium |
34493279
|
| 2022 |
The Golgi-resident ACBD3 recognizes and concentrates ligand-bound STING at specialized ER–Golgi contact sites (non-canonical ER exit sites); ACBD3 depletion impairs STING ER-to-Golgi trafficking and type-I interferon responses. |
Unbiased proteomic screen, super-resolution microscopy, live-cell imaging, ACBD3 siRNA knockdown, STING trafficking assay, IFN reporter assay |
Cell reports |
High |
36543137
|
| 2023 |
ACBD3 is recruited to the Golgi by two redundant mechanisms: (1) an MWT374-376 motif in the ACBD3 region upstream of the GOLD domain, which interacts with golgins golgin-45 and giantin; (2) interaction with SCFD1 (a Sec1/Munc-18 protein) and SEC22B (a SNARE); CRISPR-KO of SCFD1 causes ACBD3 to become cytosolic, acting upstream of golgin interactions. |
CRISPR knockout, unbiased proteomics, mutagenesis (MWT motif), co-immunoprecipitation, immunofluorescence |
Molecular biology of the cell |
High |
38134218
|
| 2023 |
ACBD3 GOLD domain directly interacts with the regulatory subunit RII of PKA, recruiting PKA holoenzyme to the Golgi; forward trafficking of proteins from the ER triggers PKA activation (release of catalytic subunit from RII) at the Golgi; ACBD3 depletion reduces Golgi-localized RII and causes constitutive PKA activation and KDEL receptor retrograde transport. |
Co-immunoprecipitation, domain mapping, PKA activity assay, siRNA knockdown, KDEL receptor trafficking assay |
The Journal of biological chemistry |
Medium |
37044218
|
| 2024 |
ACBD3 knockdown increases labile iron levels by promoting ferritinophagy, leading to ferroptosis sensitivity; this is coupled with reduced GPX4 levels and elevated polyunsaturated fatty acid-containing glycerophospholipids; knockdown of NCOA4 or Bafilomycin A1 treatment blocked ferritinophagy and impeded ferroptosis in ACBD3-depleted cells. |
siRNA knockdown, iron measurement, lipid peroxidation assay, lipidomics, ferritinophagy inhibition |
Cell biology international |
Medium |
38953242
|
| 2025 |
ACBD3 colocalizes with TBEV NS4B at ER–Golgi contact sites and promotes TBEV infection; ACBD3 depletion inhibits virus replication and causes abnormal ER transformation and reduced virion release; the proviral mechanism is independent of PI4KB recruitment, requiring the full-length ACBD3 to coordinate ER-Golgi coupling. |
siRNA knockdown, proximity proteomics, confocal/electron microscopy, viral replication assay, virion release assay |
Journal of virology |
Medium |
40207930
|
| 2025 |
ACBD3 promotes primary lung cancer growth by recruiting PI4KB to the Golgi, enhancing oncogenic secretion in chromosome 1q-amplified cells; conversely, in chromosome 1q-diploid cells, ACBD3 suppresses metastasis by inhibiting NOTCH signaling and reducing cell motility. |
CRISPR knockout, co-immunoprecipitation, cell migration/invasion assay, xenograft model, NOTCH signaling assay |
Oncogene |
Medium |
40189704
|